BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 24947639)

  • 1. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.
    Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA
    Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interleukin-4 polymorphism is associated with susceptibility to Clostridium difficile infection in patients with inflammatory bowel disease: results of a retrospective cohort study.
    Connelly TM; Koltun WA; Sangster W; Berg AS; Hegarty JP; Harris L; Deiling S; Stewart DB
    Surgery; 2014 Oct; 156(4):769-74. PubMed ID: 25239315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
    Lindberg J; Stenling R; Palmqvist R; Rutegård J
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
    D'Haens GR; Lashner BA; Hanauer SB
    Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
    Zheng HH; Jiang XL
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R; Lauwers GY; Choi WT
    J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
    Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
    Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
    Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
    Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease as a risk factor for colorectal cancer.
    Lukas M
    Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
    Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.
    Florin TH; Pandeya N; Radford-Smith GL
    Gut; 2004 Jul; 53(7):973-9. PubMed ID: 15194646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study.
    Rungoe C; Simonsen J; Riis L; Frisch M; Langholz E; Jess T
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):693-700.e1. PubMed ID: 25086189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
    Glas J; Stallhofer J; Ripke S; Wetzke M; Pfennig S; Klein W; Epplen JT; Griga T; Schiemann U; Lacher M; Koletzko S; Folwaczny M; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1737-44. PubMed ID: 19455118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.